top of page
.png)
Supported projects
CYBERNA
Specializes in diagnostic platforms that license patented chemical modifications of RNA as biomarker signatures for early cancer detection. Its multiplex technology combines mass spectrometry and machine learning to deliver scalable, low-cost solutions for in vitro diagnostic medical device partners.
PSCC's entrance
Septembre 2025
Localization
FR - Occitanie
Modality
TechBio
Development status
Medtech - Development
Award(s)
bottom of page

